Showing results (1-10 of 378) with videos related to
Sort By:
Pageof 38
Chinese Clinical Oncology|November 22, 2014
Drug designs fulfilling the requirements of clinical trials aiming at personalizing medicineSumithra J Mandrekar, Daniel J SargentJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 29, 2010
Randomized phase II trials: time for a new era in clinical trial designSumithra J Mandrekar, Daniel J SargentJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2011
All-comers versus enrichment design strategy in phase II trialsSumithra J Mandrekar, Daniel J SargentClinical Investigation|March 6, 2012
Design of clinical trials for biomarker research in oncologySumithra J Mandrekar, Daniel J SargentJournal of Biopharmaceutical Statistics|April 23, 2009
Clinical trial designs for predictive biomarker validation: one size does not fit allSumithra J Mandrekar, Daniel J SargentJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2009
Clinical trial designs for predictive biomarker validation: theoretical considerations and practical challengesSumithra J Mandrekar, Daniel J SargentClinical Trials (London, England)|April 16, 2010
Predictive biomarker validation in practice: lessons from real trialsSumithra J Mandrekar, Daniel J SargentGenome Medicine|July 30, 2009
Genomic advances and their impact on clinical trial designSumithra J Mandrekar, Daniel J SargentClinical Trials (London, England)|August 29, 2013
Statistical issues in the validation of prognostic, predictive, and surrogate biomarkersDaniel J Sargent, Sumithra J MandrekarStatistics in Medicine|April 27, 2010
Model-based phase I designs incorporating toxicity and efficacy for single and dual agent drug combinations: methods and challengesSumithra J Mandrekar, Rui Qin, Daniel J SargentPageof 38